An open up-label research was carried out in 2016 in the united kingdom to analyze the feasibility, safety and efficacy of psilocybin in managing patients with unipolar treatment-resistant depression with promising success; although the study was modest and involved only twelve clients, 7 of All those patients met formal criteria for remission just… Read More